CoChat

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Marine Microalgae with Anti-Cancer Properties

Open access
Martínez Andrade, Kevin, Lauritano, Chiara, Romano, Giovanna, Ianora, Adrianna · 2018 · Marine Drugs

Abstract

Cancer is the leading cause of death globally and finding new therapeutic agents for cancer treatment remains a major challenge in the pursuit for a cure. This paper presents an overview on microalgae with anti-cancer activities. Microalgae are eukaryotic unicellular plants that contribute up to 40% of global primary productivity. They are excellent sources of pigments, lipids, carotenoids, omega-3 fatty acids, polysaccharides, vitamins and other fine chemicals, and there is an increasing demand for their use as nutraceuticals and food supplements. Some microalgae are also reported as having anti-cancer activity. In this review, we report the microalgal species that have shown anti-cancer properties, the cancer cell lines affected by algae and the concentrations of compounds/extracts tested to induce arrest of cell growth. We also report the mediums used for growing microalgae that showed anti-cancer activity and compare the bioactivity of these microalgae with marine anticancer drugs already on the market and in phase III clinical trials. Finally, we discuss why some microalgae can be promising sources of anti-cancer compounds for future development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/md16050165

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Time estimates for research and development of new Food and Drug Administration (FDA) approved drugs.
Figure 1 Time estimates for research and development of new Food and Drug Administration (FDA) approved drugs.CC BY · PubMed Central
Figure 2 Polyunsaturated aldehydes. From left to right: 2-trans-4-cis-7-cis-decatrienal (a); 2-trans-4-trans-7-cis-decatrienal (b); 2-trans-4-trans-decadienal (c); 2-trans-4-trans-octadienal (d) and 2-trans-4-trans-heptadienal (e).
Figure 2 Polyunsaturated aldehydes. From left to right: 2-trans-4-cis-7-cis-decatrienal (a); 2-trans-4-trans-7-cis-decatrienal (b); 2-trans-4-trans-decadienal (c); 2-trans-4-trans-octadienal (d) and 2-trans-4-trans-heptadienal (e).CC BY · PubMed Central
Figure 3 Chrysolaminaran monomer.
Figure 3 Chrysolaminaran monomer.CC BY · PubMed Central
Figure 4 Violaxanthin.
Figure 4 Violaxanthin.CC BY · PubMed Central
Figure 5 Eicosapentaenoic acid.
Figure 5 Eicosapentaenoic acid.CC BY · PubMed Central
Figure 6 Fucoxanthin.
Figure 6 Fucoxanthin.CC BY · PubMed Central
Figure 7 Stigmasterol.
Figure 7 Stigmasterol.CC BY · PubMed Central
Figure 8 Nonyl 8-acetoxy-6-methyloctanoate (NAMO).
Figure 8 Nonyl 8-acetoxy-6-methyloctanoate (NAMO).CC BY · PubMed Central
Figure 9 Monogalactosyl Glycerol (Compound 1): (2S)-1-O-5,8,11,14,17-eicosapentaenoyl-2-O-6,9,12-hexadecatrienoyl-3-O-[β-d-galactopyranosyl]-glycerol.
Figure 9 Monogalactosyl Glycerol (Compound 1): (2S)-1-O-5,8,11,14,17-eicosapentaenoyl-2-O-6,9,12-hexadecatrienoyl-3-O-[β-d-galactopyranosyl]-glycerol.CC BY · PubMed Central
Figure 10 Monogalactosyl Glycerol (Compound 2): (2S)-1-O-3,6,9,12,15-octadecapentaenoyl-2-O-6,9,12,15-octadecatetraenoyl-3-O-β-d-galactopyranosyl-sn-glycerol.
Figure 10 Monogalactosyl Glycerol (Compound 2): (2S)-1-O-3,6,9,12,15-octadecapentaenoyl-2-O-6,9,12,15-octadecatetraenoyl-3-O-β-d-galactopyranosyl-sn-glycerol.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. Amaro, H., Guedes, A., and Malcata, F. (2011). Antimicrobial activities of microalgae: An invited review. Sci. Microb. Pathog. Commun. Curr. Res. Technol. Adv., 1272–1280.

Cited by

See all 284

Metadata

Authors
Martínez Andrade, K., Lauritano, C., Romano, G., & Ianora, A.
Affiliations
  • Department of Integrative Marine Ecology, Stazione Zoologica Anton Dohrn, 80121 Naples, Italy
  • Stazione Zoologica Anton Dohrn (IT)
Corresponding author
Ianora, Adrianna
Venue
Marine Drugs
Publisher
MDPI AG
Published
2018-05-15
Volume
16
Issue
5
Pages
165
ISSN
1660-3397 (ISSN-L)
OpenAlex
W2804861256
Cited by
284
References
50
Citations by year
2026: 17 · 2025: 33 · 2024: 35 · 2023: 35 · 2022: 43 · 2021: 45 · 2020: 40 · 2019: 30 · 2018: 6
FWCI
2.87
Type
journal article
Language
en
Open access
Locations
  • Marine Drugs (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Horizon 2020 (721421)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Physical Sciences › Energy › Renewable Energy, Sustainability and the Environment › Algal biology and biofuel production
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
Keywords
marine microalgae, anticancer activity, anticancer agents, cancer cell lines, growth arrest, microalgal pigments, microalgal lipids, omega-3 fatty acids, polysaccharides, nutraceuticals
MeSH terms
Antineoplastic Agents, Biological Products, Drug Screening Assays, Antitumor, Humans, Neoplasms, Clinical Trials, Phase III as Topic, Dietary Supplements, Cell Proliferation, Microalgae

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Marine Microalgae with Anti-Cancer Properties. https://app.cochat.ai/papers/10.3390/md16050165
The paper
Martínez Andrade, K., Lauritano, C., Romano, G., & Ianora, A. (2018). Marine Microalgae with Anti-Cancer Properties. Marine Drugs. https://doi.org/10.3390/md16050165

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.